Almut G. Winterstein
Almut G. Winterstein
Professor for Pharmaceutical Outcomes and Policy, University of Florida
Verified email at - Homepage
Cited by
Cited by
Validity and reliability of measurement instruments used in research
CL Kimberlin, AG Winterstein
American journal of health-system pharmacy 65 (23), 2276-2284, 2008
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection
Committee on Infectious Diseases and Bronchiolitis Guidelines Committee
Pediatrics 134 (2), e620-e638, 2014
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care
LA Thomsen, AG Winterstein, B S⊘ ndergaard, LS Haugb⊘ lle, ...
Annals of Pharmacotherapy 41 (9), 1411-1426, 2007
Preventable drug-related hospital admissions
AG Winterstein, BC Sauer, CD Hepler, C Poole
Annals of Pharmacotherapy 36 (7-8), 1238-1248, 2002
Nature of preventable adverse drug events in hospitals: a literature review
P Kanjanarat, AG Winterstein, TE Johns, RC Hatton, R Gonzalez-Rothi, ...
American journal of health-system pharmacy 60 (17), 1750-1759, 2003
Drug—drug interactions in the elderly
IK Bj÷rkman, J Fastbom, IK Schmidt, CB Bernsten, ...
Annals of Pharmacotherapy 36 (11), 1675-1681, 2002
Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care
C Bernsten, I Bj÷rkman, M Caramona, G Crealey, B Fr°kjŠr, ...
Drugs & aging 18 (1), 63-77, 2001
Multisite Investigation of Outcomes WitháImplementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention
LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ...
JACC: Cardiovascular Interventions 11 (2), 181-191, 2018
Identifying clinically significant preventable adverse drug events through a hospital’s database of adverse drug reaction reports
AG Winterstein, RC Hatton, R Gonzalez-Rothi, TE Johns, R Segal
American journal of health-system pharmacy 59 (18), 1742-1749, 2002
Potential adverse drug events and drug–drug interactions with medical and consumer cannabidiol (CBD) use
JD Brown, AG Winterstein
Journal of clinical medicine 8 (7), 989, 2019
Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder
AG Winterstein, T Gerhard, J Shuster, M Johnson, JM Zito, A Saidi
Pediatrics 120 (6), e1494-e1501, 2007
Nature and causes of clinically significant medication errors in a tertiary care hospital
AG Winterstein, TE Johns, EI Rosenberg, RC Hatton, R Gonzalez-Rothi, ...
American Journal of Health-System Pharmacy 61 (18), 1908-1916, 2004
Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database
AG Winterstein, T Gerhard, J Shuster, J Zito, M Johnson, H Liu, A Saidi
Annals of Pharmacotherapy 42 (1), 24-31, 2008
Causes of hyperglycemia and hypoglycemia in adult inpatients
WD Smith, AG Winterstein, T Johns, E Rosenberg, BC Sauer
American Journal of Health-System Pharmacy 62 (7), 714-719, 2005
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion
DJ Guervil, AF Rosenberg, AG Winterstein, NS Harris, TE Johns, ...
Annals of Pharmacotherapy 45 (7-8), 861-868, 2011
Ambulatory Care: Efficacy and Safety of Oral Phenylephrine: Systematic Review and Meta-Analysis
RC Hatton, AG Winterstein, RP McKelvey, J Shuster, L Hendeles
Annals of Pharmacotherapy 41 (3), 381-390, 2007
Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications
C Hampp, TL Kauf, AS Saidi, AG Winterstein
Archives of pediatrics & adolescent medicine 165 (6), 498-505, 2011
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder
M Olfson, C Huang, T Gerhard, AG Winterstein, S Crystal, PD Allison, ...
Journal of the American Academy of Child & Adolescent Psychiatry 51 (2), 147-156, 2012
Institutional profile: University of Florida and Shands Hospital personalized medicine program: clinical implementation of pharmacogenetics
JA Johnson, AR Elsey, MJ Clare-Salzler, D Nessl, M Conlon, DR Nelson
Pharmacogenomics 14 (7), 723-726, 2013
Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study
AG Winterstein, T Gerhard, P Kubilis, A Saidi, S Linden, S Crystal, J Zito, ...
Bmj 345, 2012
The system can't perform the operation now. Try again later.
Articles 1–20